Biogen Inc. buy Needham & Company LLC
Start price
04.09.24
/
50%
€185.95
Target price
04.09.25
€257.78
Performance (%)
-3.95%
Price
20.09.24
€178.60
Summary
This prediction is currently active. With a performance of -3.95%, the BUY prediction by Needham___Company_LL is trending in the wrong direction. This prediction currently runs until 04.09.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Biogen Inc. | 1.133% |
iShares Core DAX® | 0.347% |
iShares Nasdaq 100 | 0.715% |
iShares Nikkei 225® | 1.522% |
iShares S&P 500 | 0.631% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $285.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat